Should I Buy LOVE? LOVE 2026 Analysis

Should You Buy Lovesac Co (LOVE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

13.220

1 Day change

2.72%

52 Week Range

23.990

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now: the stock is in a bearish technical structure (SMA_200 > SMA_20 > SMA_5) and trading below the pivot (14.095), which favors sellers on rallies.
With no Intellectia buy signals today (AI Stock Picker and SwingMax both absent), there’s no strong timing edge for an impatient entry.
If you must act immediately, the only constructive setup is a tight, support-based tactical entry near S1 (~13.13); otherwise the higher-probability trade is to wait for a reclaim of ~14.10 (pivot) or a bullish MA/price reversal.

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: No signal on given stock today.

Technical Analysis

Trend: Bearish (SMA_200 > SMA_20 > SMA_5), indicating the broader downtrend is still intact.
Momentum: MACD histogram is negative (-0.191) but negatively contracting, suggesting downside momentum is easing (potential early stabilization, not confirmation of reversal).
RSI(6): 48.0 (neutral) — no oversold bounce signal, no strong bullish momentum either.
Levels to watch:
- Support: S1 13.13 (near current 13.39), then S2 12.535.
- Resistance: Pivot 14.095 (key reclaim level), then R1 15.06.
Near-term pattern-based projection: modest statistical upside over 1 week/month, but not strong enough to override the current bearish structure.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning/Sentiment: Open interest put-call ratio at 0.56 suggests more call interest than puts (mildly bullish positioning).
Flow today: Put volume is 0 and call volume is 95 → volume put-call ratio 0.0, but overall volume is not especially elevated (today vs 30D avg ~68.8%), so the signal is not “loud.”
Volatility: 30D IV 63.4 vs HV 52.9 (IV > realized) implies options are pricing in more movement than recent realized volatility.
IV trend: IV is below the 5D/10D averages (both ~81) → volatility has come down, consistent with reduced near-term fear/uncertainty.

Technical Summary

Sell

Buy

Positive Catalysts

leans modestly bullish.

Neutral/Negative Catalysts

- Clear bearish technical regime (stacked moving averages) reduces odds that an immediate entry works without a catalyst.
- Recent earnings period commentary: guidance/outlook was lowered and promotions were heavier, pressuring margins.
- Gross margin declined (53.43%, down ~4.62% YoY), a key concern for a consumer discretionary brand relying on promotions.
- No fresh news catalysts in the last week to force a re-rating upward.
- Trading trends: hedge funds and insiders are neutral — no “smart money” accumulation signal in the provided data.
- No recent politician/congress trading data to indicate influential buying support.

Financial Performance

Latest quarter: FY2026 Q3.
Revenue: 150.166M, up ~0.17% YoY (essentially flat growth; demand environment still sluggish).
Profitability: Net income -10.551M (improved YoY per dataset), EPS -0.72 (improved YoY) — losses narrowed versus prior year.
Margins: Gross margin 53.43%, down ~4.62% YoY, signaling promotion/price pressure and/or cost headwinds.
Overall read: modest improvement in bottom-line losses but margin deterioration and flat revenue make the near-term setup less compelling for an immediate buy.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Analysts kept Buy ratings but cut price targets across the board after a softer Q3 and reduced Q4 outlook:
- DA Davidson: PT cut to 18 from 24 (Buy)
- Roth Capital: PT cut to 19 from 28 (Buy)
- Maxim: PT cut to 26 from 33 (Buy)
- Canaccord: PT cut to 24 from 30 (Buy)
Wall Street pros: believes innovation/product launches, category stabilization, and longer-term margin improvement can drive recovery; valuation is viewed as attractive by at least one firm.
Wall Street cons: near-term consumer softness, tougher comps, heavier promotions and margin pressure, and reduced guidance keep confidence tempered in the short run.

6 Analyst Rating

Wall Street analysts forecast LOVE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LOVE is 23.17 USD with a low forecast of 17 USD and a high forecast of 35 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

0 Hold

0 Sell

Strong Buy

Current: 12.870

Low

Averages

23.17

High

Current: 12.870

Low

Averages

23.17

High

DA Davidson

Buy

downgrade

$24 -> $18

AI Analysis

2025-12-12

Reason

DA Davidson

Price Target

$24 -> $18

AI Analysis

2025-12-12

downgrade

Buy

Reason

DA Davidson lowered the firm's price target on Lovesac to $18 from $24 and keeps a Buy rating on the shares. The company's Q3 results came in slightly below plan and the company lowered their Q4 outlook, but the earnings call seemed to be better than the press release as Lovesac highlighted a reversion back to positive comps in the first half of Q4, helped by some promotional pricing and what seems like better industry trends, the analyst tells investors in a research note.

Roth Capital

Buy

downgrade

$28 -> $19

2025-12-12

Reason

Roth Capital

Price Target

$28 -> $19

2025-12-12

downgrade

Buy

Reason

Roth Capital lowered the firm's price target on Lovesac to $19 from $28 but keeps a Buy rating on the shares after its Q3 earnings miss. The company saw a soft patch in September/October that firmed in November and into the key Holiday period, with management confirming positive omni-comps Q4-to-date, though despite this improvement, the management lowered Q4 sales and adjusted EBITDA guidance, citing a tentative consumer, tougher comps, and heavier promotions pressuring margins, the analyst tells investors in a research note. Patient investors should focus on Lovesac's cheap valuation at 3.5-times expected EBITDA, upcoming product launches, margin improvement into the second half of FY27, and sound balance sheet, the firm added.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LOVE

Unlock Now

LOVE Should I Buy

LOVE Should I Buy

Should You Buy Lovesac Co (LOVE) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch